Wide Ranks

GELS

Gelteq Limited

1.86

Top Statistics
Market Cap 17 M Forward PE 0.0000 Revenue Growth -68.90 %
Current Ratio 0.15 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -11.04 Enterprise / Revenue 117.52 Price To Sales Trailing12 Months 133.24
Profitability
Profit Margins 0.00 % Operating Margins -732.58 %
Balance Sheet
Total Cash 399224 Total Cash Per Share 0.0490 Total Debt 2 M
Total Debt To Equity 13.34 Current Ratio 0.15 Book Value Per Share 2.00
All Measures
Message Board Id finmb_1779819906 Return On Equity -0.1875 City Caulfield
Uuid 79f3b146-3725-3ee9-8b6e-25638ad38ac8 Previous Close 1.94 First Trade Date Epoch Utc 1 B
Book Value 2.00 Total Debt 2 M Volume 14696
Price To Book 0.9295 Fifty Two Week Low 1.42 Total Cash Per Share 0.0490
Total Revenue 131758 Max Age 86400 Sand P52 Week Change 0.3133
Operating Margins -732.58 % Net Income To Common -3360893 Ask 2.24
Implied Shares Outstanding 9 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 26830 Average Volume10days 26830 Total Cash 399224
Next Fiscal Year End 1 B Revenue Per Share 0.0160 Held Percent Insiders 0.6503
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 1.94 Target Low Price 0.0000 Gmt Off Set Milliseconds -18000000
Fifty Day Average 2.07 Open 1.91 Free Cashflow -463495
State VIC Dividend Yield 0.00 % Return On Assets -0.0743
Time Zone Short Name EST Trailing Eps -0.2400 Day Low 1.86
Address1 641 Glen Huntly Road Shares Outstanding 9 M Price Hint 4
Target High Price 0.0000 Website https://www.gelteq.com 52 Week Change -0.3673
Average Volume 58400 Recommendation Key none Forward Eps 0.0000
Quick Ratio 8.10 % Is_sp_500 False Regular Market Day High 1.98
Profit Margins 0.00 % Debt To Equity 13.34 Fifty Two Week High 4.01
Day High 1.98 Shares Short 475 Regular Market Open 1.91
Industry Key drug-manufacturers-specialty-generic Bid 1.55 Earnings Growth 0.00 %
Enterprise To Revenue 117.52 Revenue Growth -68.90 % Shares Percent Shares Out 0.0001
Operating Cashflow -1217857 Currency USD Time Zone Full Name America/New_York
Market Cap 17 M Is_nasdaq_100 False Zip 3162
Quote Type EQUITY Industry Drug Manufacturers - Specialty & Generic Long Name Gelteq Limited
Regular Market Day Low 1.86 Current Price 1.86 Enterprise To Ebitda -11.04
Financial Currency AUD Current Ratio 0.15 Gross Margins 100.00 %
Industry Disp Drug Manufacturers - Specialty & Generic Country Australia Float Shares 3 M
Two Hundred Day Average 2.07 Enterprise Value 15 M Price To Sales Trailing12 Months 133.24
Forward PE 0.0000 Regular Market Volume 14696 Ebitda -1402977
Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals.

It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products.

The company was incorporated in 2017 and is headquartered in Caulfield, Australia.